▲ BUY
9
/ 10
Conviction
$ Value
$31K
Shares
9,200
Price
$3
Filed
Apr 6
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ Cluster: 3 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
GILL JOHN
Title
—
CIK
0001409939
Roles
Director
Transaction Details
Transaction Date
2026-04-06
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
21,700
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.4050 to $3.4080, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Filing Info
GILL JOHN's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-06 | ALT | ▲ | $31K |
| 2025-12-23 | ALT | ▲ | $51K ★ |
| 2025-09-25 | ALT | A | $0 |
| 2022-01-06 | ALT | G | $0 |
Other Insiders at ALT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Durso Jerome Benedict
President and CEO
|
$47K | — | 2026-04-01 |
|
WEAVER GREGORY L
Chief Financial Officer
|
$31K | — | 2026-04-01 |
| Garg Vipin K | — | — | 2026-01-31 |
|
Roberts M Scot
Chief Scientific Officer
|
— | — | 2026-02-26 |
|
Jordt Raymond M
Chief Business Officer
|
— | — | 2026-01-31 |